NCT01598454: Use of Racotumomab in Patients With Pediatric Tumors Expressing N-glycolylated Gangliosides |
|
|
| Completed | 1 | 15 | RoW | racotumomab | Laboratorio Elea Phoenix S.A., Ministerio de Ciencia e Innovación, Spain | Neuroblastoma, Ewing's Sarcoma, Wilm's Tumor, Retinoblastoma, Glioma | 03/14 | 06/15 | | |
